The pharmaceutical industry’s reliance on medical licenses and the frameworks surrounding them underscores the importance of compliance as a core driver of trust and safety. From clinical trials to marketing and physician engagement, the stakes could not be higher. Through his consulting work, Richard Katz demonstrates that compliance should be seen not as a barrier to progress but as its foundation. By embedding regulatory foresight into strategic planning, he helps organizations thrive in a complex landscape, ensuring innovations reach the patients who need them most.